Author:
Drusano G. L.,Standiford H. C.,Bustamante C. I.,Forrest A.,Rivera G.,Tatem B.,Schimpff S. C.
Publisher
Springer Science and Business Media LLC
Subject
Microbiology (medical),Microbiology,Infectious Diseases,Microbiology (medical),General Medicine
Reference9 articles.
1. Tally, F. P., Jacobus, N. V., Gorbach, S. L.: In vitro activity of N-formimidoyl thienamycin (MK-787). Antimicrobial Agents and Chemotherapy 1980, 18: 642–644.
2. Livingstone, W. K., Elliot, A. M., Cobbs, C. G.: In vitro activity of N-formimidoyl thienamycin (MK-787) against resistant strains ofPseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens andEnterococcus spp. Antimicrobial Agents and Chemotherapy 1981, 19: 114–116.
3. Brown, J. E., Del Bene, V. E., Collins, C. D.: In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents againstBacteroides fragilis: contribution of beta-lactamase to resistance. Antimicrobial Agents and Chemotherapy 1981, 19: 248–252.
4. Graballese, D. A., Musson, D. G., Paulinkouis, L. T., Bayne, W. F.: Determination of imipenem (N-formimidoyl thienamycin) in human plasma and urine by HPLC methodology: comparison with microbiological methodology and stability. Journal of Chromatography (in press).
5. D'Argenio, D. Z., Schumitzky, A.: A program package for simulation and parameter estimation in pharmacokinetic systems. Computer Programs in Biomedicine 1979, 9: 115–134.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献